0001776700-19-000001.txt : 20190514 0001776700-19-000001.hdr.sgml : 20190514 20190514105040 ACCESSION NUMBER: 0001776700-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITANOVA BIOMEDICAL, INC. CENTRAL INDEX KEY: 0001776700 IRS NUMBER: 471205206 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339524 FILM NUMBER: 19821044 BUSINESS ADDRESS: STREET 1: 222 SIDNEY BAKER ST. STREET 2: SUITE 635 CITY: KERRVILLE STATE: TX ZIP: 78028 BUSINESS PHONE: 317-730-5955 MAIL ADDRESS: STREET 1: 222 SIDNEY BAKER ST. STREET 2: SUITE 635 CITY: KERRVILLE STATE: TX ZIP: 78028 D 1 primary_doc.xml X0708 D LIVE 0001776700 VITANOVA BIOMEDICAL, INC. 222 SIDNEY BAKER ST. SUITE 635 KERRVILLE TX TEXAS 78028 317-730-5955 TEXAS None None Corporation true 2014 THOMAS ROBERTS C/O VITANOVA BIOMEDICAL, INC. 222 SIDNEY BAKER ST., SUITE 635 KERRVILLE TX TEXAS 78028 Executive Officer Director President and Chief Executive Officer GREG ESPENHOVER C/O VITANOVA BIOMEDICAL, INC. 222 SIDNEY BAKER ST., SUITE 635 KERRVILLE TX TEXAS 78028 Executive Officer Director Chief Financing Officer MATTHEW GDOVIN C/O VITANOVA BIOMEDICAL, INC. 222 SIDNEY BAKER ST., SUITE 635 KERRVILLE TX TEXAS 78028 Executive Officer Director Chief Science Officer Biotechnology Decline to Disclose 06b false 2018-02-01 true true false 5000 420000 420000 0 This offering covers the sale and issuance of convertible promissory notes and the preferred and/or common stock issuable upon conversion thereof. false 8 0 0 220000 true false VITANOVA BIOMEDICAL, INC. /s/ Thomas Roberts Thomas Roberts President and CEO 2019-05-11